NASDAQ:ASRT
Assertio Therapeutics Stock News
$1.00
+0 (+0%)
At Close: May 28, 2024
Assertio Completed Merger with Zyla Life Sciences
12:48pm, Wednesday, 20'th May 2020
Assertio Holdings, Inc., the successor issuer to Assertio Therapeutics, Inc., ("Assertio" ) (NASDAQ: ASRT) announced the closing of the merger with Zyla Life Sciences. The combined company (the "Compa
One Analyst's Earnings Estimates For Assertio Therapeutics, Inc. (NASDAQ:ASRT) Are Surging Higher
12:09pm, Sunday, 17'th May 2020
Assertio Therapeutics, Inc. (NASDAQ:ASRT) shareholders will have a reason to smile today, with the covering analyst...
Assertio Therapeutics, Inc. (ASRT) CEO Arthur Higgins on Q1 2020 Results - Earnings Call Transcript
05:06pm, Monday, 11'th May 2020
Assertio Therapeutics, Inc. (NASDAQ:ASRT) Q1 2020 Earnings Conference Call May 11, 2020 8:30 AM ET Company Participants Max Nemmers - Director, Human Resources
10-Q: ASSERTIO THERAPEUTICS, INC
03:12pm, Monday, 11'th May 2020
(EDGAR Online via COMTEX) --
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FORWARD-LOOKING INFORMATION...
Assertio (ASRT) Beats Q1 Earnings and Revenue Estimates
02:35pm, Monday, 11'th May 2020
Assertio (ASRT) delivered earnings and revenue surprises of 225.00% and 85.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Assertio Therapeutics Q1 Earnings
12:17pm, Monday, 11'th May 2020
Shares of Assertio Therapeutics (NASDAQ:ASRT) rose 9% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share decreased 56.52% over the past year to $0.10, whi
Assertio Therapeutics Announces First-Quarter 2020 Results
12:00pm, Monday, 11'th May 2020
-- Completed Strategic Asset Sales of NUCYNTA® Franchise and Gralise® Totaling $502.5 Million -- -- Repaid Senior Secured Debt in Full and Successfully Tendered for Convertible.
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates The Merger Of Assertio Therapeutics, Inc.; Investors Are Encouraged To Contact The Firm
02:41am, Saturday, 09'th May 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Assertio Therapeutics, Inc. (NASDAQ: ASRT) and Zyla Life Sciences is fair to Assertio shareholders.
NEW YORK, NY / ACCESSWIRE / May 8, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Assertio Therapeutics, Inc. (NASDAQ:ASRT) and Zyla Life Scien
SHAREHOLDER ALERT: WeissLaw LLP Investigates Assertio Therapeutics, Inc.
11:02pm, Friday, 08'th May 2020
URGENT: STOCKHOLDER VOTE MAY 19, 2020
Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for
04:30pm, Wednesday, 06'th May 2020
Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy This Biotech That Makes A Lower Risk Painkiller?
10:20am, Tuesday, 21'st Apr 2020
A company making abuse-deterrent opioids and that's barely listed in any nation-wide opioid litigation is becoming a rising star despite the prescription overdose crisis.
Assertio Therapeutics, Inc. (“Assertio” or “the Company”) (ASRT) today announced the date of its 2020 Annual Meeting, which will be held as a virtual meeting on May 19, 2020. The Company also
Activist hedge fund Starboard pounces on U.S. companies in turmoil
07:00pm, Wednesday, 15'th Apr 2020
Most activist shareholders have refrained from challenging the boards of U.S. companies during this season of annual shareholder meetings, as businesses reel from the economic fallout of the coronavir
